Filter Results:
(1,651)
Show Results For
- All HBS Web
(1,651)
- People (11)
- News (516)
- Research (864)
- Events (1)
- Multimedia (9)
- Faculty Publications (362)
Show Results For
- All HBS Web
(1,651)
- People (11)
- News (516)
- Research (864)
- Events (1)
- Multimedia (9)
- Faculty Publications (362)
- 18 Oct 2021
- Blog Post
Embracing Activism for Social Change
high-impact nonprofit or public sector positions for a year at a competitive salary. For Mendu, that meant the chance to work with Detroit’s former Chief Policy Officer Kim Rustem on a number of initiatives including the development and launch of the city’s Mental... View Details
- Web
PhD Programs - Doctoral
requirements and curriculum, read student profiles as well as student research , and placement information. The PhD in Business Administration grounds students in the disciplinary theories and research methods that form the foundation of... View Details
- 04 Nov 2016
- News
New war on drugs: Pharma becoming 'uninvestable'?
- Article
Four Things No One Will Tell You About ESG Data
By: Sakis Kotsantonis and George Serafeim
As the ESG finance field and the use of ESG data in investment decision-making continue to grow, the authors seek to shed light on several important aspects of ESG measurement and data. This article is intended to provide a useful guide for the rapidly rising number of... View Details
Keywords: ESG; ESG (Environmental, Social, Governance) Performance; ESG Reporting; Data Analytics; Sustainability; Sustainability Reporting; CSR; Transparency; Investment Management; Socially Responsible Investing; Sustainable Finance; Sustainable Development; Inclusion; Inclusive Growth; Corporate Social Responsibility and Impact; Corporate Accountability; Investment; Management; Climate Change; Corporate Governance; Diversity; Integrated Corporate Reporting
Kotsantonis, Sakis, and George Serafeim. "Four Things No One Will Tell You About ESG Data." Journal of Applied Corporate Finance 31, no. 2 (Spring 2019): 50–58.
Paul A. Gompers
Paul Gompers, Professor of Business Administration at the Harvard Business School, specializes in research on financial issues related to start-up, high growth, and newly public companies. Professor Gompers has an appointment in both the View Details
Keywords: health care; health care; health care; health care; health care; health care; health care; health care
- 03 Jan 2007
- First Look
First Look: January 3, 2007
Working PapersCan Higher Prices Stimulate Product Use? Evidence from a Field Experiment in Zambia Authors:Nava Ashraf, James Berry, and Jesse M. Shapiro Abstract The pricing of health products in the developing world has become a center... View Details
Keywords: Sean Silverthorne
- 2013
- Working Paper
Increased Speed Equals Increased Wait: The Impact of a Reduction in Emergency Department Ultrasound Order Processing Time
By: Jillian Berry Jaeker, Anita L. Tucker and Michael H. Lee
We exploit an exogenous process change at two emergency departments (EDs) within a health system to test the theory that increasing capacity in a discretionary work setting increases wait times due to additional services being provided to customers as a consequence of... View Details
Keywords: Technology; Demand and Consumers; Service Delivery; Health Care and Treatment; Business Processes; Health Industry
Berry Jaeker, Jillian, Anita L. Tucker, and Michael H. Lee. "Increased Speed Equals Increased Wait: The Impact of a Reduction in Emergency Department Ultrasound Order Processing Time." Harvard Business School Working Paper, No. 14-033, October 2013.
- 2008
- Book
On Competition
By: M. E. Porter
Competition is one of society's most powerful forces for making things better in many fields of human endeavor. The study of competition and the creation of value, in their full richness, have preoccupied me for several decades. Competition is pervasive, whether it... View Details
Porter, M. E. On Competition. Updated and Expanded Ed. Boston: Harvard Business School Publishing, 2008.
- April 2009 (Revised November 2012)
- Case
Sermo, Inc.
By: Thomas R. Eisenmann and Lars Peter Christian Nielsen
Sermo operates the leading online professional network for physicians in the United States. Doctors use Sermo free of charge to post surveys regarding diagnostic and treatment concerns and to discuss these concerns, as well as challenges with managing their practices.... View Details
Keywords: Entrepreneurship; Health Care and Treatment; Knowledge Sharing; Two-Sided Platforms; Conflict and Resolution; Social and Collaborative Networks; United States
Eisenmann, Thomas R., and Lars Peter Christian Nielsen. "Sermo, Inc." Harvard Business School Case 809-142, April 2009. (Revised November 2012.)
- 19 Dec 2023
- Research & Ideas
$15 Billion in Five Years: What Data Tells Us About MacKenzie Scott’s Philanthropy
comparison group. Top causes: education and health care Between 2020 and 2022, nonprofits in the youth, philanthropy, and housing sectors represented a larger share of grantees compared with the size of those segments of charitable giving... View Details
- Program
Leading in the Digital Era
leadership responsibilities, including but not limited to division heads, functional heads, or executives with P&L responsibility Executives in medium to large organizations in any country or industry, including organizations with digitally driven business models as... View Details
- February 2020
- Supplement
Theranos: Who Has Blood on Their Hands? (B)
By: Nien-he Hsieh, Christina R. Wing and John Masko
This supplemental case tracks the results of the Colman and Taubman-Dye class action suit against Theranos as well as Theranos’ other legal challenges and chronicles the final demise of the company in 2019. View Details
Keywords: Health Testing and Trials; Corporate Accountability; Organizational Culture; Misleading and Fraudulent Advertising; Crime and Corruption; Entrepreneurship; Lawsuits and Litigation; Business Exit or Shutdown; Medical Devices and Supplies Industry; California; United States
Hsieh, Nien-he, Christina R. Wing, and John Masko. "Theranos: Who Has Blood on Their Hands? (B)." Harvard Business School Supplement 320-091, February 2020.
- Web
Capstone | MBA
cellular signaling. Recently, it has been appreciated that these drugs can provide benefits to patients with severe mental health disorders including depression and addiction. This project described an approach to modify these psychedelic... View Details
- Web
HBS Working Knowledge – Harvard Business School Faculty Research
three working Americans with criminal records from the economy? In a case study, Paul Gompers explores the challenges a social justice startup encounters in helping the formerly incarcerated, as well as lessons for other entrepreneurs. 12... View Details
- November 2005 (Revised November 2005)
- Case
Massachusetts General Hospital and the Enbrel Royalty
By: David S. Scharfstein and Darren R. Smart
Massachusetts General Hospital is considering selling its royalty interest in Enbrel, Amgen's blockbuster drug for the treatment of rheumatoid arthritis. In assessing whether to sell, and at what price, the hospital must determine its value to a potential buyer as well... View Details
Keywords: Valuation; Price; Investment Return; Capital; Value; Revenue; Health Care and Treatment; Health Industry; Health Industry; Massachusetts
Scharfstein, David S., and Darren R. Smart. "Massachusetts General Hospital and the Enbrel Royalty." Harvard Business School Case 206-075, November 2005. (Revised November 2005.)
- 13 Jan 2021
- Blog Post
Staying Curious with the Harvard Innovation Labs Ahead of the 2021 Virtual President’s Innovation Challenge
What is the President’s Innovation Challenge (PIC)? The President’s Innovation Challenge (PIC) is a call to action for Harvard students and alumni pursuing ventures that push the boundaries of their fields. We have five total tracks and three student tracks in the... View Details
- 12 Aug 2002
- Op-Ed
Using Big Business to Fight Poverty
and have become active politically. Health facilities have also improved. Although this operation will eventually turn a profit for DaimlerChrysler, it could not have happened without the help of the German and Brazilian governments. This... View Details
Keywords: by George C. Lodge
- 20 Feb 2018
- News
EHRs fall short in reducing administrative costs
- Article
A Feasibility Study Using Time-driven Activity-based Costing as a Management Tool for Provider Cost Estimation: Lessons from the National TB Control Program in Zimbabwe in 2018
By: J. Chirenda, B. Nhlema Simwaka, C. Sandy, K. Bodnar, S. Corbin, P. Desai, T. Mapako, S. Shamu, C. Timire, E. Antonio, A. Makone, A. Birikorang, T. Mapuranga, M. Ngwenya, T. Masunda, M. Dube, E. Wandwalo, L. Morrison and R. S. Kaplan
Background: This study used process maps and time-driven activity-based costing to document TB service delivery processes. The analysis identified the resources required to sustain TB services in Zimbabwe, as well as several opportunities for more effective and... View Details
Keywords: Time-Driven Activity-Based Costing; Provider Cost; Health Care and Treatment; Cost Management; Activity Based Costing and Management; Zimbabwe
Chirenda, J., B. Nhlema Simwaka, C. Sandy, K. Bodnar, S. Corbin, P. Desai, T. Mapako, S. Shamu, C. Timire, E. Antonio, A. Makone, A. Birikorang, T. Mapuranga, M. Ngwenya, T. Masunda, M. Dube, E. Wandwalo, L. Morrison, and R. S. Kaplan. "A Feasibility Study Using Time-driven Activity-based Costing as a Management Tool for Provider Cost Estimation: Lessons from the National TB Control Program in Zimbabwe in 2018." BMC Health Services Research 21, no. 242 (2021).
- Web
Faculty & Advisors | MBA
Faculty & Advisors MS/MBA Biotechnology: Life Sciences Faculty Amitabh Chandra, Ph.D. Henry and Allison McCance Professor of Business Administration at HBS, Ethel Zimmerman Winer Professor of Public Policy and Director of Health Policy... View Details